Repligen RGEN
$163.81 −$6.48 (-3.81%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $163.81 0.00%
Open$169.61
Prev close$170.29
Day range$162.47 – $169.61
Volume697.7K
Market cap$10.47B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$209.31M+10.9% YoY
Operating profit$12.96M+2.2% YoY
Net profit-$38.43M-357.7% YoY
Diluted EPS-$0.68-361.5% YoY
Free cash flow$37.82M-11.5% YoY
Operating cash flow$43.10M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin53.5%
Operating margin7.6%
Net margin-1.5%
Return on equity-0.6%
Return on assets-0.4%
Return on invested capital0.1%
Current ratio9.88
Liabilities / assets28.5%
Cash & investments$862.98M
Total debt$671.84M
Net cash (debt)$191.14M
Free cash flow / sales13.1%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $209.31M | $204.13M | $194.26M | $738.26M | $197.91M |
| Total Operating Revenue | $209.31M | $204.13M | $194.26M | $738.26M | $197.91M |
| Cost of Revenue | $98.33M | $94.09M | $85.97M | $352.01M | $96.55M |
| Gross Profit | $110.99M | $110.04M | $108.28M | $386.25M | $101.36M |
| Operating Expense | $98.03M | $91.04M | $90.99M | $344.69M | $89.15M |
| Selling and Admin Expenses | $83.59M | $76.62M | $76.54M | $290.51M | $75.23M |
| Research & Development | $14.44M | $14.42M | $14.46M | $54.18M | $13.92M |
| Operating Profit | $12.96M | $19.00M | $17.29M | $41.56M | $12.21M |
| Net Non-Operating Interest Income (Expense) | -$6.13M | -$6.08M | -$6.00M | -$23.17M | -$5.91M |
| Non-Operating Interest Expense | $5.71M | $5.66M | $5.58M | $21.51M | $5.50M |
| Total Other Finance Costs | $422,000.00 | $421,000.00 | $419,000.00 | $1.66M | $417,000.00 |
| Other Income (Expense) | -$33.63M | $1.24M | -$9.52M | $44.00M | $12.81M |
| Gain on Sale of Security | $7.00M | $6.43M | $6.34M | $27.57M | $6.75M |
| Special Income (Charges) | -$42.54M | -$4.92M | -$15.11M | $13.61M | $5.66M |
| -Less:Restructuring and Mergern & Acquisition | $1.26M | $5.03M | $1.35M | -$13.61M | -$5.66M |
| -Less:Impairment of Capital Assets | $41.24M | – | – | – | – |
| -Gain on Sale Of Business | -$34,000.00 | $103,000.00 | -$13.76M | – | – |
| Other Non-Operating Income (Expenses) | $1.91M | -$273,000.00 | -$750,000.00 | $2.82M | $403,000.00 |
| Pretax Profit | -$26.81M | $14.15M | $1.77M | $62.38M | $19.11M |
| Tax | $11.62M | $9.15M | -$6.56M | $13.49M | $5.83M |
| Net Profit | -$38.43M | $5.01M | $8.33M | $48.89M | $13.29M |
| Profit from Continuing Operations | -$38.43M | $5.01M | $8.33M | $48.89M | $13.29M |
| Net Income to Parent Company | -$38.43M | $5.01M | $8.33M | $48.89M | $13.29M |
| Net Income to Common Stockholders | -$38.43M | $5.01M | $8.33M | $48.89M | $13.29M |
| Basic EPS | -$0.68 | $0.09 | $0.15 | $0.87 | $0.24 |
| Diluted EPS | -$0.68 | $0.09 | $0.15 | $0.86 | $0.23 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.93B | $2.95B | $2.93B | $2.95B | $2.95B |
| Total Current Assets | $1.24B | $1.20B | $1.16B | $1.14B | $1.14B |
| Cash and Cash Equivalents & Short-Term Investments | $862.98M | $810.45M | $784.53M | $767.63M | $767.63M |
| -Cash and Cash Equivalents | $726.96M | $606.78M | $582.65M | $566.02M | $566.02M |
| -Short Term Investments | $136.02M | $203.67M | $201.88M | $201.61M | $201.61M |
| Receivables | $151.24M | $157.71M | $151.55M | $158.59M | $158.59M |
| -Accounts Receivable | $151.24M | $157.71M | $151.55M | $158.59M | $158.59M |
| Inventory | $182.21M | $186.60M | $179.26M | $170.46M | $170.46M |
| Other Current Assets | $45.57M | $45.79M | $46.02M | $27.14M | $27.14M |
| Total Non-Current Assets | $1.68B | $1.75B | $1.77B | $1.81B | $1.81B |
| Net PPE | $276.03M | $283.07M | $287.11M | $306.15M | $306.15M |
| -Gross PPE | $276.03M | $283.07M | $287.11M | $510.03M | $510.03M |
| Goodwill and Other Intangible Assets | $1.41B | $1.46B | $1.48B | $1.50B | $1.50B |
| -Goodwill | $1.10B | $1.10B | $1.11B | $1.11B | $1.11B |
| -Other Intangible Assets | $305.29M | $357.62M | $368.19M | $386.15M | $386.15M |
| Non-Current Deferred Assets | $716,000.00 | $700,000.00 | $1.36M | $694,000.00 | $694,000.00 |
| Other Non-Current Assets | $2.07M | $4.05M | $5.88M | $4.91M | $4.91M |
| Total Liabilities | $834.67M | $838.15M | $825.31M | $843.57M | $843.57M |
| Total Current Liabilities | $125.69M | $132.66M | $126.21M | $135.83M | $135.83M |
| Payables | $28.46M | $33.65M | $35.55M | $33.60M | $33.60M |
| -Accounts Payable | $27.70M | $33.23M | $34.66M | $30.01M | $30.01M |
| -Total Tax Payable | $763,000.00 | $413,000.00 | $897,000.00 | $3.59M | $3.59M |
| Current Accrued Expenses | $25.71M | $25.87M | $19.77M | $20.87M | $20.87M |
| Short-Term Debt and Capital Lease Obligation | $20.40M | $19.32M | $21.07M | $21.56M | $21.56M |
| -Current Capital Lease Obligation | $20.40M | $19.32M | $21.07M | $21.56M | $21.56M |
| Current Deferred Liabilities | $15.79M | $19.60M | $18.31M | $14.61M | $14.61M |
| Other Current Liabilities | $2.25M | $3.03M | $5.23M | $5.05M | $5.05M |
| Total Non-Current Liabilities | $708.99M | $705.49M | $699.10M | $707.74M | $707.74M |
| Long Term Debt and Capital Lease Obligation | $671.84M | $671.62M | $666.55M | $668.39M | $668.39M |
| -Long Term Debt | $555.60M | $551.05M | $546.59M | $542.21M | $542.21M |
| -Long Term Capital Lease Obligation | $116.25M | $120.58M | $119.96M | $126.18M | $126.18M |
| Non-Current Deferred Liabilities | $19.91M | $16.78M | $15.02M | $22.50M | $22.50M |
| Other Non-Current Liabilities | $17.23M | $17.09M | $17.53M | $16.86M | $16.86M |
| Total Equity | $2.09B | $2.11B | $2.11B | $2.11B | $2.11B |
| Stockholders' Equity | $2.09B | $2.11B | $2.11B | $2.11B | $2.11B |
| Capital Stock | $567,000.00 | $564,000.00 | $564,000.00 | $563,000.00 | $563,000.00 |
| -Common Stock | $567,000.00 | $564,000.00 | $564,000.00 | $563,000.00 | $563,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.69B | $1.66B | $1.65B | $1.65B | $1.65B |
| Retained Earnings | $431.16M | $469.59M | $464.58M | $456.25M | $456.25M |
| Gains/Losses Not Affecting Retained Earnings | -$25.61M | -$19.79M | -$14.31M | -$2.53M | -$2.53M |
| Prepaid Assets | – | – | – | $13.57M | $13.57M |
| -Accumulated Depreciation | – | – | – | -$203.88M | -$203.88M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $43.10M | $32.77M | $28.30M | $117.42M | $25.70M |
| Net cash flow from continuing operations | $43.10M | $32.77M | $28.30M | $117.42M | $25.70M |
| Net Income from Continuing Operations | -$38.43M | $5.01M | $8.33M | $48.89M | $13.29M |
| Gain/Loss from Continuing Operations | -$530,000.00 | -$260,000.00 | $13.80M | – | – |
| Depreciation & Depletion & Amortization | $23.83M | $23.77M | $24.54M | $96.96M | $24.59M |
| Deferred Tax | $3.83M | $2.93M | -$7.70M | -$3.37M | $2.41M |
| Other Non-Cash Items | $3.91M | $6.28M | $2.90M | -$6.79M | -$10.66M |
| Change in Working Capital | -$102,000.00 | -$12.97M | -$21.90M | -$50.88M | -$24.35M |
| -Change in Receivables | $7.75M | -$7.55M | $3.19M | -$17.17M | -$9.86M |
| -Change in Inventory | $4.09M | -$8.09M | -$12.07M | -$14.95M | -$9.60M |
| -Change in Prepaid Assets | $2.23M | -$3.98M | -$1.98M | -$7.76M | -$2.26M |
| -Change in Payables and Accrued Expense | -$8.55M | $12.32M | -$6.74M | $7.66M | $3.12M |
| -Change in Other Current Assets | $22,000.00 | $1.87M | $26,000.00 | -$1.56M | $167,000.00 |
| -Change in Other Current Liabilities | -$5.64M | -$7.54M | -$4.33M | -$17.12M | -$5.91M |
| Net cash flow from investing | $63.99M | -$2.09M | -$3.99M | -$298.47M | -$208.74M |
| Net Cash Flow from Continuing Investing Activities | $63.99M | -$2.09M | -$3.99M | -$298.47M | -$208.74M |
| Capital Expenditure | -$335,000.00 | -$735,000.00 | -$237,000.00 | -$2.21M | -$156,000.00 |
| Net PPE Purchase and Sale | -$4.95M | -$5.33M | -$4.71M | -$23.28M | -$7.96M |
| Net Business Purchase and Sale | $0.00 | $3.64M | $0.00 | -$70.33M | -$374,000.00 |
| Net Investment Purchase and Sale | $69.27M | -$73,000.00 | $1.38M | -$200.26M | -$200.26M |
| Financing Cash Flow | $14.60M | -$6.20M | -$5.54M | -$15.21M | $195,000.00 |
| Net Cash Flow from Continuing Financing Activities | $14.60M | -$6.20M | -$5.54M | -$15.21M | $195,000.00 |
| Proceeds from Stock Option Exercised | $15.76M | $94,000.00 | $0.00 | $3.18M | $1.03M |
| Net Other Financing Charges | -$1.15M | -$6.29M | -$5.54M | -$18.38M | -$839,000.00 |
| Ending Cash Balance | $729.01M | $608.81M | $584.64M | $566.02M | $566.02M |
| Net Change in Cash | $121.69M | $24.48M | $18.76M | -$196.26M | -$182.85M |
| Beginning Cash Balance | $608.81M | $584.64M | $566.02M | $757.36M | $748.75M |
| Effect of Exchange Rate Changes | -$1.49M | -$311,000.00 | -$145,000.00 | $4.93M | $119,000.00 |
| Free Cash Flow | $37.82M | $26.70M | $23.35M | $91.69M | $17.40M |
| Net Other Investing Changes | – | – | -$416,000.00 | -$2.40M | $0.00 |
| Net Intangibles Purchase and Sale | – | – | – | $0.00 | – |
| Net Issuance Payments Of Debt | – | – | – | $0.00 | $0.00 |
| Net Common Stock Issuance | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on RGEN.
Sign in to join the discussion.